Association Between C-Reactive Protein and Biomarkers of Bone and Mineral Metabolism in Chronic Hemodialysis Patients: A Cross-Sectional Study

Journal of Renal Nutrition

Volumn 19, Issue 3, 2009, Pages 220-227

  Lee, Chien Te ^a   Tsai, Yu Che ^a   Ng, Hwee Yeong ^a   Su, Yih ^b   Lee, Wen Chin ^a   Lee, Lung Chih ^a   Chiou, Terry Ting Yu ^a   Liao, Shang Chih ^a   Hsu, Kao Tai ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHENG SHIU UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CALCIUM; MINERAL; PHOSPHATE;

ARTICLE; BLOOD; BONE; CHRONIC DISEASE; CHRONIC KIDNEY FAILURE; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; INFLAMMATION; MALE; METABOLISM; MIDDLE AGED; RENAL REPLACEMENT THERAPY;

BIOLOGICAL MARKERS; BONE AND BONES; C-REACTIVE PROTEIN; CALCIUM; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INFLAMMATION; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MINERALS; PHOSPHATES; RENAL DIALYSIS;

EID: 64949119892     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2008.11.004     Document Type: Article

References (28)

1. Foley R.N., Parfrey P.S., and Sarnak M.J. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32 Suppl 3 (1998) 112-119
2. McCullough P.A. Cardiovascular disease in chronic kidney disease from one cardiologist's perspective. Curr Opin Nephrol Hypertens 13 (2004) 591-560
3. Yeun J.Y., Levine R.A., Mantadilok V., et al. C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 35 (2000) 469-476
4. Kaysen G.A. Role of inflammation and its treatment in ESRD patients. Blood Purif 20 (2002) 70-80
5. Tsai Y.C., Lee C.T., Huang T.L., et al. Inflammatory marker but not adipokine predict mortality among chronic hemodialysis patients. Mediators Inflamm 2007, 19891 (2007)
6. Moe S., Drueke T., Cunningham J., et al. Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 69 (2006) 1945-1953
7. Block G.A., Klassen P.S., Lazarus J.M., et al. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15 (2004) 2208-2218
8. Young E.W., Albert J.M., Satayathum S., et al. Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study. Kidney Int 67 (2005) 1179-1187
9. Slinin Y., Foley R.N., and Collins A.J. Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS Waves 1, 3, and 4 Study. J Am Soc Nephrol 16 (2005) 1788-1793
10. London G.M., Guerin A.P., Marchais S.J., et al. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 18 (2003) 1731-1740
11. Goldsmoth D., Ritz E., and Covic A. Vascular calcification: a stiff challenge for the nephrologists. Kidney Int 66 (2004) 1315-1333
12. Cannata-Andía J.B., Rodríguez-García M., Carrillo-López N., et al. Vascular calcifications: pathogenesis, management, and impact on clinical outcomes. J Am Soc Nephrol 17 (2006) S267-S273
13. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42 Suppl 4 (2003) S1-S201
14. Young E.W., Akiba T., Albert J.M., et al. Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 44 Suppl 2 (2004) 34-38
15. Tomasello S., Dhupar S., and Sherman R. Phosphate binders, K/DOQI guidelines, and compliance: the unfortunate reality. Dial Transplant 33 (2004) 236-242
16. Ho L.T., and Sprague S.M. Renal osteodystrophy in chronic renal failure. Am J Kidney Dis 22 (2002) 488-493
17. Kalantar-Zadeh K., Kuwae N., Regidor D.L., et al. Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int 70 (2006) 771-780
18. Blacher J., Guerin A.P., Pannier B., et al. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 38 (2001) 938-942
19. Wang A.Y., Wang M., Woo J., et al. Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: a prospective study. J Am Soc Nephrol 14 (2003) 159-168
20. London G.M., Marchais S.J., Guerin A.P., et al. Arteriosclerosis, vascular calcifications and cardiovascular disease in uremia. Curr Opin Nephrol Hypertens 14 (2005) 525-531
21. Goodman W.G., London G., Amann K., et al. Vascular calcification in chronic kidney disease. Am J Kidney Dis 43 (2004) 572-579
22. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115-126
23. Floege J., and Ketteler M. Vascular calcification in patients with end-stage renal disease. Nephrol Dial Transplant 19 Suppl 5 (2004) v59-v66
24. Ketteler M. Fetuin-A and extraosseous calcification in uremia. Curr Opin Nephrol Hypertens 14 (2005) 337-342
25. Brancaccio D., Tetta C., Gallieni M., et al. Inflammation, CRP, calcium overload and a high calcium-phosphate product: a "liaison dangereuse. Nephrol Dial Transplant 17 (2002) 201-203
26. Block G.A., Hulbert-Shearon T.E., Levin N.W., et al. Association of serum phosphorus and calcium × phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 31 (1998) 607-617
27. Movilli E., Feliciani A., Camerini C., et al. A high calcium-phosphate product is associated with high C-reactive protein concentrations in hemodialysis patients. Nephron Clin Pract 101 (2005) c161-c167
28. Kalpakian M.A., and Mehrotra R. Vascular calcification and disordered mineral metabolism in dialysis patients. Semin Dial 20 (2007) 139-143